For laboratory research use only

HealthyWelness
Account Cart0 Order now

How to Store Reconstituted Peptides: Fridge, Freezer, Time

Do peptides need refrigeration once reconstituted? Why solutions degrade faster than powder, how long they keep, time out of the fridge and freezing aliquots.

Yes, reconstituted peptides should be refrigerated at 2–8 °C and protected from light. Dissolving a peptide removes the main protection that freeze-drying provides, which is the absence of water. In solution, chemical and physical degradation proceed much faster, and temperature, light, pH and handling all affect how quickly.

For laboratory research use only. The compounds discussed are not approved for human or veterinary use and are not drugs, foods or cosmetics. This article summarises published research and is not medical advice.

Key points

Why solutions degrade faster than powder

Protein and peptide stability reviews group degradation into chemical pathways (covalent changes) and physical pathways (changes in structure or association state). Water participates in, or enables, most of them (Manning et al., 2010).

PathwayWhat happensResidues most affectedSpeeds up with
HydrolysisPeptide bond cleavageAsp–Pro, Asp–Gly bondsLow pH, heat
DeamidationAsn/Gln converted to Asp/Glu (+1 Da)Asn–Gly, Asn–SerNeutral–basic pH, heat
OxidationAddition of oxygen (+16 Da)Met, Cys, Trp, HisAir, light, metal ions
AggregationPeptides associate into oligomers or particlesHydrophobic or amphipathic sequencesAgitation, freezing, high concentration
AdsorptionPeptide sticks to glass or plasticHydrophobic, cationic peptidesLow concentration

A review focused on peptides in aqueous formulations concluded that pH optimisation and buffer choice are the most practical ways to slow these reactions, followed by air exclusion, co-solvents and viscosity enhancers (Nugrahadi et al., 2023). Research solutions made in unbuffered bacteriostatic or sterile water have none of these protections, which is why cold storage carries most of the load.

Storage conditions compared

ConditionSuitable forMain risk
2–8 °C, darkWorking solution in routine useSlow chemical degradation over weeks
Room temperature (20–25 °C)Minutes, during samplingDegradation rates several-fold higher than at 2–8 °C
−20 °C, single-use aliquotsLonger storage of a solutionFreeze–thaw aggregation, concentration changes during freezing
Repeated freeze–thaw of one vialNot recommendedCumulative aggregation
Light exposure (bench, window)Not recommendedPhoto-oxidation

Time out of the fridge

Degradation is roughly cumulative: a vial that spends an hour on the bench every day accumulates days of room-temperature exposure over a month. Practical rules:

Freezing reconstituted peptides

Freezing slows chemistry but adds physical stress. As water crystallises, peptide and solutes concentrate in the remaining liquid, pH can shift, and ice–liquid interfaces form. Industrial studies treat freeze–thaw as a major cause of aggregation and characterise it carefully before manufacturing (Jain et al., 2021). Benzyl alcohol makes this worse: in a 2026 study it exacerbated freeze–thaw-induced aggregation of a monoclonal antibody (Xu et al., 2026).

If you need to freeze a peptide solution:

  1. Reconstitute in sterile water rather than bacteriostatic water.
  2. Divide immediately into single-use aliquots in low-binding tubes.
  3. Freeze once at −20 °C or below; thaw each aliquot once and do not refreeze.

Handling that extends usable life

How long is “too long”?

Commonly cited in-use periods for reconstituted research peptides, often a few weeks at 2–8 °C, are rules of thumb rather than measured values for each sequence. Peptides with methionine, asparagine–glycine motifs or strong aggregation tendency will be at the shorter end. Where results depend on the peptide being intact, the reliable approach is to compare an HPLC chromatogram of the stored solution with the lot’s certificate of analysis.

The solvent vial has its own rules; see does bacteriostatic water need to be refrigerated? Our bacteriostatic water is supplied in 3 mL and 10 mL vials.

Related research

Frequently asked questions

Do reconstituted peptides need to be refrigerated?

Yes, in almost all cases. Once dissolved, peptides are exposed to hydrolysis, deamidation, oxidation and aggregation, all of which slow at lower temperature. The standard is 2–8 °C, protected from light.

How long do reconstituted peptides last in the fridge?

It depends on the sequence, solvent, pH and concentration, and for most research peptides no published stability study exists. Treat any figure as a working limit to be confirmed by HPLC for critical work, and date every vial.

How long can reconstituted peptides be out of the fridge?

Short excursions at room temperature, such as the minutes needed to withdraw a sample, are generally tolerated. Hours or days at room temperature accelerate degradation, and the effect accumulates; return the vial to 2–8 °C promptly.

Can you freeze reconstituted peptides?

Freezing can extend storage, but each freeze–thaw cycle can promote aggregation. If freezing is necessary, divide the solution into single-use aliquots in sterile water rather than freezing a bacteriostatic-water vial repeatedly.

Do peptides need to be refrigerated before reconstitution?

Lyophilized powder is far more stable than solution. For long-term storage −20 °C is standard; many peptides tolerate refrigeration or short periods at room temperature in sealed, dry vials. See the guide to lyophilized peptide storage.

References

  1. Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010. PMID: 20143256 https://pubmed.ncbi.nlm.nih.gov/20143256/
  2. Nugrahadi PP, et al. Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics. 2023. PMID: 36986796 https://pubmed.ncbi.nlm.nih.gov/36986796/
  3. Jain K, et al. Freeze-thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics. Sci Rep. 2021. PMID: 34059716 https://pubmed.ncbi.nlm.nih.gov/34059716/
  4. Xu ZT, et al. Benzyl alcohol exacerbates freeze-thaw-induced aggregation of trastuzumab: elucidating mechanisms and formulation implications for clinical practice. Int J Pharm. 2026. PMID: 41325828 https://pubmed.ncbi.nlm.nih.gov/41325828/
  5. Schöneich C. Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects. Pharm Res. 2020. PMID: 32016661 https://pubmed.ncbi.nlm.nih.gov/32016661/
  6. Treuheit MJ, et al. Inverse relationship of protein concentration and aggregation. Pharm Res. 2002. PMID: 12033388 https://pubmed.ncbi.nlm.nih.gov/12033388/

For laboratory research use only. The compounds discussed are not approved for human or veterinary use and are not drugs, foods or cosmetics. This article summarises published research and is not medical advice.

Sources

  1. Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010. PMID: 20143256
  2. Nugrahadi PP, et al. Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics. 2023. PMID: 36986796
  3. Jain K, et al. Freeze-thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics. Sci Rep. 2021. PMID: 34059716
  4. Xu ZT, et al. Benzyl alcohol exacerbates freeze-thaw-induced aggregation of trastuzumab: elucidating mechanisms and formulation implications for clinical practice. Int J Pharm. 2026. PMID: 41325828
  5. Schöneich C. Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects. Pharm Res. 2020. PMID: 32016661
  6. Treuheit MJ, et al. Inverse relationship of protein concentration and aggregation. Pharm Res. 2002. PMID: 12033388
Chat on WhatsAppMon–Sat, 09:00–21:00 (UTC+8)